a Spectacular Goal from Colorado Avalanche vs. Arizona Coyotes
Reuters
Novavax, after delays, files for U.S. authorization of COVID-19 vaccine
(Reuters) -Novavax Inc said on Monday it has filed for emergency use authorization of its COVID-19 vaccine for U.S. adults, a long-awaited step for the company following months of struggles with development and manufacturing problems. The filing is based on data provided to the U.S. Food and Drug Administration last month and results of two late-stage trials in the United States, Mexico and the UK that showed the protein-based vaccine had an overall efficacy of about 90%, the company said. “We believe our vaccine offers a differentiated option… that can be an alternative to the portfolio of available vaccines to help fight the COVID-19 pandemic,” said Novavax Chief Executive Officer Stanley Erck in a statement.
Source: Yahoo Sports
